The 23-Valent Pneumoccocal (Pneumovax) Vaccine: For Which Patients?

Poll

For which of these patients would you give the 23-valent pneumoccocal vaccine?

Which of the following should get the 23-valent pneumoccocal (Pneumovax) vaccine per the Advisory Committee on Immunization Practices (ACIP) guidelines?

19-year-old who smokes a pack a day
16-year-old with diabetes mellitus
70-year-old who previously received a dose at age 64
All of the above
Recent Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Interview with Kelly Moore, MD, MPH, president, chief executive officer, Immunization Action Coalition
Related Content
ACIP Expands RSV Vaccine Recommendation to At‑Risk Adults Aged 50–59 Years

ACIP Expands RSV Vaccine Recommendation to At‑Risk Adults Aged 50–59 Years

Sydney Jennings
April 17th 2025
Article

The CDC advisory committee also endorsed GSK's pentavalent meningococcal vaccine.

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Keith A. Reynolds
October 1st 2024
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

RSV Vaccine Uptake Low Among Eligible Populations, Large-Scale Analysis Finds

RSV Vaccine Uptake Low Among Eligible Populations, Large-Scale Analysis Finds

Sydney Jennings
April 9th 2025
Article

AAAAI 2025: RSV vaccine and immunoprophylaxis uptake remained low in 2024 across infants, pregnant individuals, and older adults.

Respiratory Tripledemic 2022-23: An Expert Recap

Respiratory Tripledemic 2022-23: An Expert Recap

Sydney Jennings
April 6th 2023
Podcast

William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.

Antibiotic Overuse for Asymptomatic UTIs: Daily Dose / image credit: ©New Africa/AdobeStock

Antibiotic Overuse for Asymptomatic UTIs: Daily Dose

Sydney Jennings
April 9th 2025
Article

Your daily dose of the clinical news you may have missed.

FDA Approves Gepotidacin for Treatment of Uncomplicated UTIs: Daily Dose / image credit: ©New Africa/AdobeStock

FDA Approves Gepotidacin for Treatment of Uncomplicated UTIs: Daily Dose

Sydney Jennings
April 7th 2025
Article

Your daily dose of the clinical news you may have missed.

© 2025 MJH Life Sciences

All rights reserved.